Source:http://linkedlifedata.com/resource/pubmed/id/10233418
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1999-6-24
|
pubmed:abstractText |
Multiple myeloma (MM) plasma cells (PC) are CD38+. A ligand for CD38 is the adhesion molecule CD31. By flow cytometry and immunocytochemistry we have investigated whether malignant PC co-express CD38 and CD31. All 68 patients studied were CD38+. 14/14 monoclonal gammopathies of undetermined significance (MGUS) and 39/39 plasmacytic MM patients co-expressed CD38 and CD31 at high density. Only 1/11 plasmablastic MM and 1/4 plasma cell leukaemias (PCL) expressed CD31. These data indicated that PC malignancies co-expressed high levels of both CD38 and its ligand CD31, with the exception of plasmablastic MM and PCL.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0007-1048
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
105
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
441-4
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10233418-5'-Nucleotidase,
pubmed-meshheading:10233418-Aged,
pubmed-meshheading:10233418-Antigens, CD31,
pubmed-meshheading:10233418-Female,
pubmed-meshheading:10233418-Flow Cytometry,
pubmed-meshheading:10233418-Humans,
pubmed-meshheading:10233418-Immunohistochemistry,
pubmed-meshheading:10233418-Male,
pubmed-meshheading:10233418-Middle Aged,
pubmed-meshheading:10233418-Multiple Myeloma,
pubmed-meshheading:10233418-Plasma Cells
|
pubmed:year |
1999
|
pubmed:articleTitle |
Human myeloma cells express the CD38 ligand CD31.
|
pubmed:affiliation |
Dipartimento di Scienze Biomediche e Oncologia Umana, Università di Torino, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|